Immunocompromised patients are allowed and need vaccination!

The use of immunosuppressive or immunomodulatory the­ra­pies in various pathologies leads to a major risk of in­fec­tions, representing a significant cause of morbidity and mor­ta­lity for these patients. In structuring the preventive stra­te­gy, characterizing the pathology that motivates the im­mu­no­sup­pres­sion, understanding the mechanism of ac­tion of the immunosuppressant, evaluating previous in­fec­tions, recognizing risk factors, performing laboratory scre­enings, administering vaccines, educating the pa­tient, and monitoring clinical symptoms and signs are es­sen­tial, depending on necessarily individualized clinical ma­nage­ment. Vaccination, as a strategy for preventing in­fec­tions, in children and adults, plays a crucial role in im­mu­no­com­pro­mised individuals. The CDC and ECDC guidelines spe­cify which vaccines are recommended for patients with com­pro­mised immunity. Nationally, the Ministry of Health has adopted these recommendations and established the vac­cines and the method of compensation for this category of patients.